Celldex Therapeutics Inc CLDX:NASDAQ

Last Price$27.00NASDAQ Previous Close - Last Trade as of 3:58PM ET 5/24/22

Today's Change-2.62(8.85%)
Bid (Size)$24.90 (2)
Ask (Size)$28.00 (144)
Day Low / High$25.17 - 29.31
Volume1.0 M

View Medical Specialties IndustryPeer Comparison as of 05/24/2022


Celldex Therapeutics Inc ( NASDAQ )

Price: $27.00
Change: -2.62 (8.85%)
Volume: 1.0 M
3:58PM ET 5/24/2022

Avanos Medical Inc ( NYSE )

Price: $27.39
Change: -0.32 (1.15%)
Volume: 151.2 K
7:00PM ET 5/24/2022

CareDx Inc ( NASDAQ )

Price: $23.28
Change: 0.00 (0.00%)
Volume: 1.9 M
4:00PM ET 5/24/2022

Nevro Corp ( NYSE )

Price: $43.20
Change: -2.36 (5.18%)
Volume: 451.7 K
7:00PM ET 5/24/2022

Natus Medical Inc ( NASDAQ )

Price: $32.81
Change: -0.06 (0.18%)
Volume: 744.9 K
3:58PM ET 5/24/2022

Company Profile

Business DescriptionCelldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ. View company web site for more details
AddressPerryville III Building
Hampton, New Jersey 08827
Number of Employees137
Recent SEC Filing05/05/20228-K
President, Chief Executive Officer & DirectorAnthony S. Marucci
CFO, Secretary, Treasurer & Senior Vice PresidentSam Martin
Chief Scientific Officer & Executive VPTibor Keler
Chief Medical Officer & Senior Vice PresidentDiane C. Young

Company Highlights

Price Open$29.31
Previous Close$29.62
52 Week Range$25.17 - 57.20
Market Capitalization$1.3 B
Shares Outstanding46.8 M
SectorHealth Technology
IndustryMedical Specialties
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.69
Beta vs. S&P 500N/A
Revenue$9.5 M
Net Profit Margin-1,860.01%
Return on Equity-21.45%

Analyst Ratings as of 09/16/2021

Consensus RecommendationConsensus Icon
Powered by Factset